what is microdosing tirzepatide pros and cons of GLP-1 agonists—using doses below FDA-approved levels for T2D or obesity—is rapidly gaining traction as an Microdosing Tirzepatide Program | No

The most frequently reported side effects of Mounjaro are gastrointestinal in nature , reflecting the medication's mechanism of slowing gastric emptying and affecting gut motility

Potential heart benefits A study originally published in the J ournal of Experimental and Therapeutic Medicine found that some GLP-1 medications may lower the risk of heart disease

It has been established through clinical trials that GLP-1 receptor agonists (liraglutide and semaglutide) have proven to be consistently useful in lowering body weight, enhancing glycaemic control, and reducing cardiovascular risk [7,8,9].Nevertheless, since GLP-1 receptor agonists have the capability to work on several central nervous pathways, including the one controlling appetite, reward circuits, and the pancreatic-enteric-brain axis, the potential psychological impact of such agonists has increased with time [10,11,12]

If side effects become difficult to manage, you should contact your healthcare provider for advice